Cytokinetics sec filings
WebThis will confirm the agreement by and among the undersigned that the Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the Common Stock, par value $0.001 per share, of Cytokinetics, Incorporated, a Delaware corporation, will be filed on behalf of … WebMar 27, 2024 · INVESTORS & MEDIA SEC FILINGS SEC Filing Keyword Search Group Filing year Items per page 10 1 2 3 4 5 6 7 8 9 … Next › Last » Displaying 1 - 10 of 1876 results Mar 07 2024 10:35 am EST Data Provided by Refinitiv. Minimum 15 minutes delayed. STOCK CHART
Cytokinetics sec filings
Did you know?
WebPipeline - Cytokinetics A pipeline powered by passion pipeline Research Pre-Clinical Phase 1 Phase 2 Phase 3 CARDIAC MUSCLE Omecamtiv Mecarbil (Heart Failure) Aficamten (oHCM) Aficamten (nHCM) CK-136 (Heart Failure, other) CK-586 SKELETAL MUSCLE Reldesemtiv (ALS) Additional Skeletal Muscle Activators Other Muscle Biology … WebJul 1, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in …
WebMar 15, 2024 · Wed., March 15, 2024 MarketBeat Advisory Research Inc. lowered its holdings in Cytokinetics, Incorporated ( NASDAQ:CYTK - Get Rating) by 32.7% during the third quarter, according to its most recent filing with the …
WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. WebApr 13, 2024 · China Universal Asset Management Co. Ltd. trimmed its holdings in Cytokinetics, Incorporated (NASDAQ:CYTK – Get Rating) by 96.6% during the 4th …
WebFind the latest SEC Filings data for Cytokinetics, Incorporated Common Stock (CYTK) at Nasdaq.com. Cytokinetics, Incorporated Common Stock (CYTK) SEC Filings …
WebFeb 25, 2024 · Cytokinetics Inc (CYTK) SEC Filing 10-K Annual Report for the fiscal year ending Friday, December 31, 2024 Earnings Press Release 10-K Annual Report 10-K … dwight and mose paintingWebFind the latest Cytokinetics, Incorporated (CYTK) stock quote, history, news and other vital information to help you with your stock trading and investing. ... SEC Filings. GlobeNewswire ... dwight andre sean o\u0027neil jonesWebFeb 28, 2024 · Cytokinetics Stock Up 0.4 %. Shares of CYTK opened at $42.98 on Tuesday. Cytokinetics, Incorporated has a 52 week low of $33.10 and a 52 week high of $55.80. The firm has a market cap of $4.07 billion, a P/E ratio of -13.60 and a beta of 0.90. The firm's 50-day simple moving average is $43.66 and its 200 day simple moving … crystaline battle wandWebApr 10, 2024 · SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 22 nd Annual Needham Virtual Healthcare Conference on Monday, April 17, 2024 at 10:00 … crystaline burger vhWebApr 8, 2024 · Cytokinetics Inc (CYTK) SEC Filing DEF 14A Proxy Statement Report for the fiscal year ending Tuesday, May 10, 2024. Home. SEC Filings. ... Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats. Last10K.com Member Feature. Export Annual and Quarterly Reports to Adobe Acrobat (PDF), Microsoft Word (DOCX), … crystal in ears treatment videoWebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Our Vision. ... SEC Filings. Annual Report and Proxy. Analyst Coverage. Investor FAQ. IR/Media Contacts. Corporate Governance. Information Request. Email Alerts. dwight andrews emoryWebApr 13, 2024 · China Universal Asset Management Co. Ltd.’s holdings in Cytokinetics were worth $44,000 as of its most recent filing with the Securities & Exchange Commission. Several other large investors have also made changes to their positions in CYTK. Advisor Group Holdings Inc. lifted its position in shares of Cytokinetics by 14.9% in the first quarter. dwight and mh jackson